Jia-Wei-Yu-Ping-Feng-San Attenuates Group 2 Innate Lymphoid Cell-Mediated Airway Inflammation in Allergic Asthma
The incidence of asthma has increased in recent decades. Although corticosteroids and bronchodilators are used in clinical practice, the control of asthma remains a challenge. Allergic asthma is characterized airway inflammation mediated by type 2 immune response. Group 2 innate lymphoid cells (ILC2...
Main Authors: | Lingna Xue, Cui Li, Guangbo Ge, Shaoyan Zhang, Liming Tian, Yu Wang, Huiyong Zhang, Zifeng Ma, Zhenhui Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-07-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2021.703724/full |
Similar Items
-
A mini review of Yu-Ping-Feng polysaccharides: Their biological activities and potential applications in aquaculture
by: Yang Liu, et al.
Published: (2021-07-01) -
Effects of YuPingFeng granules on acute exacerbations of COPD: a randomized, placebo-controlled study
by: Ma JF, et al.
Published: (2018-10-01) -
A Chinese Prescription Yu-Ping-Feng-San Administered in Remission Restores Bronchial Epithelial Barrier to Inhibit House Dust Mite-Induced Asthma Recurrence
by: Kaifan Bao, et al.
Published: (2020-01-01) -
The Mechanisms of Yu Ping Feng San in Tracking the Cisplatin-Resistance by Regulating ATP-Binding Cassette Transporter and Glutathione S-Transferase in Lung Cancer Cells
by: Yingqing Du, et al.
Published: (2021-05-01) -
The Ancient Chinese Decoction Yu-Ping-Feng Suppresses Orthotopic Lewis Lung Cancer Tumor Growth Through Increasing M1 Macrophage Polarization and CD4+ T Cell Cytotoxicity
by: Lixin Wang, et al.
Published: (2019-11-01)